Sabra Health Care REIT Files 8-K on Shareholder Matters

TL;DR

Sabra Health Care REIT filed an 8-K for shareholder votes. Keep an eye on what they're voting on.

AI Summary

Sabra Health Care REIT, Inc. filed an 8-K on June 13, 2024, to report on the submission of matters to a vote of its security holders. The filing details the company's corporate information, including its principal executive offices in Irvine, California, and its fiscal year end of December 31.

Why It Matters

This filing indicates that Sabra Health Care REIT, Inc. is engaging with its shareholders on important corporate decisions, which could impact the company's governance and future direction.

Risk Assessment

Risk Level: low — This filing is procedural and reports on standard corporate governance matters, not indicating immediate financial distress or significant operational changes.

Key Players & Entities

• Sabra Health Care REIT, Inc. (company) — Registrant
• June 13, 2024 (date) — Date of earliest event reported
• Irvine, CA (location) — Principal executive offices
• Maryland (location) — State of Incorporation

FAQ

Key Financial Figures

• $0.01 — ange on which registered Common stock, $0.01 par value SBRA The Nasdaq Stock Market

Filing Documents

• sbra-20240613.htm (8-K) — 49KB
• 0001492298-24-000017.txt ( ) — 176KB
• sbra-20240613.xsd (EX-101.SCH) — 2KB
• sbra-20240613_lab.xml (EX-101.LAB) — 23KB
• sbra-20240613_pre.xml (EX-101.PRE) — 13KB
• sbra-20240613_htm.xml (XML) — 3KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. (a) The annual meeting of stockholders of the Company (the "Annual Meeting") was held on June 13, 2024. (b) At the Annual Meeting, the Company's stockholders (i) elected the eight nominees identified in the table below to the Board of Directors of the Company to serve until the Company's 2025 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified ("Election of Directors"), (ii) ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 ("Auditor Ratification") and (iii) approved, on an advisory basis, the compensation of the Company's named executive officers as set forth in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 26, 2024 ("Advisory Compensation Vote"). Set forth below are the final voting tallies for the Annual Meeting: Election of Directors For Against Abstain Broker Non-Votes Craig A. Barbarosh 178,428,516 5,521,821 274,585 20,348,072 Katie Cusack 182,845,024 1,157,705 222,193 20,348,072 Michael J. Foster 178,035,739 5,953,979 235,204 20,348,072 Lynne S. Katzmann 178,856,098 5,143,790 225,034 20,348,072 Ann Kono 183,255,819 746,479 222,624 20,348,072 Jeffrey A. Malehorn 181,745,903 2,233,784 245,235 20,348,072 Richard K. Matros 174,454,780 7,542,822 2,227,320 20,348,072 Clifton J. Porter II 182,591,758 1,400,982 232,182 20,348,072 Auditor Ratification For Against Abstain Broker Non-Votes 202,131,049 2,268,764 173,181 — Advisory Compensation Vote For Against Abstain Broker Non-Votes 173,769,737 10,001,666 453,519 20,348,072

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SABRA HEALTH CARE REIT, INC. Date: June 13, 2024 /S/ MICHAEL COSTA Name: Michael Costa Title: Chief Financial Officer, Secretary and Executive Vice President

View Full Filing

View this 8-K filing on SEC EDGAR